Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients

Molecular Psychiatry
Konasale M PrasadM S Keshavan

Abstract

Polymorphisms of the gene encoding the regulator of G-protein signaling subtype 4 (RGS4) may confer risk for schizophrenia.(1) DNA microarray studies of postmortem brain samples have shown RGS4 underexpression in the dorsolateral prefrontal cortex (DLPFC, area 9), motor and visual cortices in schizophrenia patients relative to control subjects.(2) Underexpression of RGS4 in DLPFC is pathophysiologically significant because DLPFC pathology in schizophrenia has been supported by neurocognitive,(3,4) structural(5) and functional(6,7) imaging, postmortem,(8) cellular(9,10) and molecular(11) pathological studies. For these reasons, we examined the association of DLPFC gray matter volume with RGS4 polymorphisms in a series of antipsychotic-naive first-episode schizophrenia patients and control subjects. We hypothesized that volumetric alterations of the DLPFC would be associated with RGS4 polymorphisms and that these differences would be more pronounced in patients than in controls. We observed robust volumetric differences across the genotypes in the pooled sample of patients and control subjects; when separately analyzed, we observed differences within the patient group (n = 30) but not in control subject (n = 27) group. The findin...Continue Reading

References

Oct 1, 1995·Archives of General Psychiatry·G TsaiJ T Coyle
Nov 19, 1994·Lancet·M S KeshavanJ W Pettegrew
Jan 1, 1997·Schizophrenia Bulletin·P S Goldman-Rakic, L D Selemon
Jan 23, 1999·Biological Psychiatry·L D Selemon, P S Goldman-Rakic
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·L De VriesM G Farquhar
Mar 20, 2001·Archives of General Psychiatry·D M BarchJ D Cohen
Apr 3, 2001·The American Journal of Psychiatry·A R GilbertM S Keshavan
May 10, 2001·Schizophrenia Research·M E ShentonR W McCarley
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Guochuan Tsai, Joseph T Coyle
May 25, 2002·Human Molecular Genetics·Kodavali V ChowdariVishwajit L Nimgaonkar
Jun 8, 2002·Annual Review of Neuroscience·David A Lewis, Pat Levitt
Jan 21, 2004·Biological Psychiatry·Nigel M WilliamsMichael C O'Donovan
Feb 3, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Derek W MorrisAiden P Corvin

❮ Previous
Next ❯

Citations

Aug 21, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniel Paul Eisenberg, Karen Faith Berman
Oct 13, 2006·Molecular Psychiatry·K M R PrasadV L Nimgaonkar
Mar 6, 2013·Nucleic Acids Research·Shengjun HongMomiao Xiong
Feb 14, 2006·Schizophrenia Bulletin·Michael E TalkowskiVishwajit L Nimgaonkar
May 23, 2007·Schizophrenia Bulletin·Kodavali V ChowdariVishwajit L Nimgaonkar
Mar 14, 2009·Schizophrenia Bulletin·Konasale M PrasadVishwajit L Nimgaonkar
Apr 30, 2009·Annual Review of Nutrition·Mariken de KromSusanne E la Fleur
Aug 25, 2007·Annual Review of Clinical Psychology·Tyrone D Cannon, Matthew C Keller
May 10, 2008·Pharmacogenomics·Daniel B Campbell, Pat Levitt
Aug 3, 2007·International Review of Psychiatry·Matcheri S KeshavanGodfrey Pearlson
Jan 29, 2016·BMC Systems Biology·Wenyi QinHui Lu
Dec 15, 2015·Molecular Pharmacology·Kyle J GerberJohn R Hepler
Feb 25, 2011·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Amy F T Arnsten
Sep 8, 2010·Neurochemistry International·Guadalupe RiveroJ Javier Meana
Jun 1, 2009·Asian Journal of Psychiatry·Rishikesh V Behere
Jul 25, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rodrigo D PazKuei Y Tseng
Apr 25, 2008·Neuroscience Letters·Kaija HuuhkaEsa Leinonen
Feb 17, 2007·Pharmacology & Therapeutics·Brian P Ramos, Amy F T Arnsten
Feb 6, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·H Le-NiculescuA B Niculescu
Jun 20, 2006·Neuroscience and Biobehavioral Reviews·Colm M P O'TuathaighJohn L Waddington
Feb 23, 2011·Journal of Receptor and Signal Transduction Research·Dianne M Perez, Van A Doze
Feb 12, 2008·Schizophrenia Research·Daniel B CampbellPatrick F Sullivan
Aug 6, 2013·Schizophrenia Research·M S LenerK M Prasad
May 26, 2017·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Emanuel Schwarz
May 15, 2008·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Claudia Mehler-Wex, Tobias J Renner
Jun 3, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ingrid AgartzErik G Jönsson
Aug 28, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Hon-Cheong SoPak C Sham
Mar 12, 2008·Current Opinion in Psychiatry·Neeltje E van HarenRené S Kahn
Jan 22, 2008·Journal of Clinical Psychopharmacology·Hsien-Yuan LaneGuochuan E Tsai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here